Efficacy of azelnidipine versus nifedipine for the treatment of hypertension in type 2 diabetes patients with stage 1-2 nephropathy

Next Previous
Trial Profile

Efficacy of azelnidipine versus nifedipine for the treatment of hypertension in type 2 diabetes patients with stage 1-2 nephropathy

Completed
Phase of Trial: Phase III

Latest Information Update: 04 Oct 2012

At a glance

  • Drugs Azelnidipine (Primary) ; Nifedipine (Primary) ; Valsartan
  • Indications Hypertension in diabetes
  • Focus Therapeutic Use

    • Most Recent Events

    • 04 Oct 2012 Results presented at the 24th Scientific Meeting of the International Society of Hypertension.
    • 29 Apr 2012 Results presented at the 22nd European Meeting on Hypertension.
    • 20 Jun 2011 Results presented at the 21st European Meeting on Hypertension.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top